6618 — JD Health International Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeLarge CapHigh Flyer

Annual cashflow statement for JD Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-17,235	-1,073	383	2,143	4,157
Depreciation
Non-Cash Items	18,051	2,241	2,168	629	-1,537
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2,856	2,199	3,213	1,606	1,497
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,699	3,431	5,905	4,605	4,332
Capital Expenditures	-38.8	-518	-2,273	-69.3	-46.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,804	-17,234	-1,963	-7,954	3,193
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,843	-17,752	-4,236	-8,023	3,146
Financing Cash Flow Items	-219	-75	-8.85	-14.3	-8.19
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	32,029	-164	-925	-117	-45.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	27,306	-15,018	1,465	-3,681	7,592